Maternal occupational chemical exposures and biotransformation genotypes as risk factors for selected congenital anomalies

American Journal of Epidemiology

Volumn 157, Issue 6, 2003, Pages 475-484

  Shaw, Gary M ^a   Nelson, Verne ^a   Iovannisci, David M ^b   Finnell, Richard H ^c   Lammer, Edward J ^b  

^a California Birth Defects Monitoring Program   (United States)

^b CHILDREN S HOSPITAL OAKLAND   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Abnormalities; Cleft lip; Cleft palate; Genes; Heart defects, congenital; Limb deformities, congenital; Occupational exposure; Pregnancy

Indexed keywords

ACYLTRANSFERASE; CHEMICAL AGENT; DYE; GLUTATHIONE TRANSFERASE; INSECTICIDE; PIGMENT; PROPELLANT;

CHILD HEALTH; HEALTH RISK; MATERNAL HEALTH; MEDICAL GEOGRAPHY; OCCUPATION; POLLUTION EXPOSURE; RISK FACTOR; WOMENS EMPLOYMENT;

ARTICLE; BIOTRANSFORMATION; CASE CONTROL STUDY; CLEFT LIP; CLEFT PALATE; CONGENITAL HEART DISEASE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DELIVERY; ENVIRONMENTAL EXPOSURE; FEMALE; FETUS; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; INFANT; LIMB DEFECT; MAJOR CLINICAL STUDY; NEWBORN; OCCUPATIONAL EXPOSURE; OCCUPATIONAL TOXICOLOGY; PRENATAL EXPOSURE; RISK ASSESSMENT; RISK FACTOR; STILLBIRTH; UNITED STATES;

ABNORMALITIES, DRUG-INDUCED; BIOTRANSFORMATION; CALIFORNIA; CASE-CONTROL STUDIES; CLEFT LIP; CLEFT PALATE; CONFIDENCE INTERVALS; EXTREMITIES; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; INFANT, NEWBORN; OCCUPATIONAL EXPOSURE; PREGNANCY; RISK FACTORS;

EID: 0037443593     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwg013     Document Type: Article

References (48)

1. Shaw GM, Gold EB. Methodological considerations in the study of parental occupational exposures and congenital malformations in offspring. Scand J Work Environ Health 1988;14:344-55.
2. Garcia AM. Occupational exposure to pesticides and congenital malformations: a review of mechanisms, methods, and results. Am J Ind Med 1998;33:232-40.
3. Shaw GM, Velie EM, Katz EA, et al. Maternal occupational and hobby chemical exposures as risk factors for neural tube defects. Epidemiology 1999;10:124-9.
4. Gerin M, Siemiatycki J, Kemper H, et al. Obtaining occupational exposure histories in epidemiologic case-control studies. J Occup Med 1985;27:420-6.
5. Siemiatycki J, Day NE, Fabry J, et al. Discovering carcinogens in the occupational environment: a novel epidemiologic approach. J Natl Cancer Inst 1981;66:217-25.
6. Katz EA, Shaw GM, Schaffer DM. Exposure assessment in epidemiologic studies of birth defects by industrial hygiene review of maternal interviews. Am J Ind Med 1994;26:1-11.
7. Bouyer J, Hemon D. Retrospective evaluation of occupational exposures in population-based case-control studies: general overview with special attention to job exposure matrices. Int J Epidemiol 1993;22(suppl 2):S57-64.
8. Nebert DW. Polymorphisms in drug-metabolizing enzymes: what is their clinical relevance and why do they exist? Am J Hum Genet 1997;60:265-71.
9. Fantel A. A reactive oxygen species in developmental toxicity: review and hypothesis. Teratology 1996;53:196-217.
10. Liu L, Wells PG. DNA oxidation as a potential molecular mechanism mediating drug-induced birth defects; phenytoin and structurally related teratogens initiate the formation of 8-hydroxy-2-deoxyguanosine in vitro and in vivo in murine maternal hepatic and embryonic tissues. Free Radic Biol Med 1995;19:639-48.
11. Manchester D, Jacoby E. Decreased placental monooxygenase activities associated with birth defects. Teratology 1984;30:31-7.
12. Shaw GM, Wasserman CR, Lammer EJ, et al. Orofacial clefts, parental cigarette smoking, and transforming growth factor-alpha gene variants. Am J Hum Genet 1996;58:551-61.
13. Wasserman CR, Shaw GM, O'Malley CD, et al. Parental cigarette smoking and risk for congenital anomalies of the heart, neural tube, or limb. Teratology 1996;53:261-7.
14. Gosselin RE, Smith RP, Hodge HC, et al. Clinical toxicology of commercial products. 5th ed. Baltimore, MD: Williams & Wilkins, 1984.
15. Hawley GG. The condensed chemical dictionary. 10th ed. New York, NY: van Nostrand Reinhold Company, 1981.
16. Micromedex. POISINDEX. CD-ROM database. Denver, CO: Micromedex, 1991.
17. Hazardous Materials Planning Program. AB 2185 and AB 2187, California Health and Safety Code, division 20, chap 6.95. Sacramento, CA: California Department of Toxic Substances Control, 1988.
18. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
19. Iovannisci DM. Highly efficient recovery of DNA from dried blood using the MasterPure™ complete DNA and RNA purification kit. Epicentre Forum 2000;7:6-8.
20. Tsongalis GJ, Rainey BJ, Hodges KA. READIT: a novel technology used in the interrogation of nucleic acid sequences for single nucleotide polymorphisms. Exp Mol Pathol 2001;71:222-5.
21. Deitz AC, Doll MA, Hein DW. A restriction fragment length polymorphism assay that differentiates human N-acetyltransferase-1 (NAT1) alleles. Anal Biochem 1997;253:219-24.
22. Doll MA, Fretland AJ, Deitz AC, et al. Determination of human NAT2 acetylator genotype by restriction fragment-length polymorphism and allele-specific amplification. Anal Biochem 1995;231:413-20.
23. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997;6:733-43.
24. Seidegard J, Vorachek WR, Pero RW, et al. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci U S A 1988;85:7293-7.
25. Arand M, Muhlbauer R, Hengstler J, et al. A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione-S-transferase GSTM1 and GSTT1 polymorphisms. Anal Biochem 1996;236:184-6.
26. Ambrosone CB, Freudenheim JL, Graham S, et al. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer. JAMA 1996;276:1494-501.
27. Bianchi F, Cianciulli D, Pierini A, et al. Congenital malformations and maternal occupation: a registry based case-control study. Occup Environ Med 1997;54:223-8.
28. Lorente C, Cordier S, Bergeret A, et al. Maternal occupational risk factors for oral clefts. Scand J Work Environ Health 2000;26:137-45.
29. Hemminki K, Mutanen P, Luoma K, et al. Congenital malformations by the parental occupation in Finland. Int Arch Occup Environ Health 1980;46:93-8.
30. Lin S, Gensburg L, Marshall EG, et al. Effects of maternal work activity during pregnancy on infant malformations. J Occup Environ Med 1998;40:829-34.
31. Holmberg PC, Hernberg S, Kurppa K, et al. Oral clefts and organic solvent exposure during pregnancy. Int Arch Occup Environ Health 1982;50:371-6.
32. Cordier S, Ha M-C, Ayme S, et al. Maternal occupational exposure and congenital malformations. Scand J Work Environ Health 1992;18:11-17.
33. Tikkanen J, Heinonen OP. Cardiovascular malformations and organic solvent exposure during pregnancy in Finland. Am J Ind Med 1988;14:1-8.
34. Shaw GM, Malcoe LH, Katz E. Maternal workplace exposures to organic solvents and congenital cardiac anomalies. J Occup Med Toxicol 1992;1:371-6.
35. Cordier S, Bergeret A, Goujard J, et al. Congenital malformations and maternal occupational exposure to glycol ethers. Occupational Exposure and Congenital Malformations Working Group. Epidemiology 1997;8:355-63.
36. Swaminathan S, Frederickson SM, Hatcher JF. Metabolic activation of N-hydroxy-4-acetylaminobiphenyl by cultured human breast epithelial cell line MCF 10A. Carcinogenesis 1994;15:611-17.
37. Eldridge SR, Gould MN, Butterworth BE. Genotoxicity of environmental agents in human mammary epithelial cells. Cancer Res 1992;52:5617-21.
38. Bell DA, Badawi AF, Lang NP, et al. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res 1995;55:5226-9.
39. Badawi AF, Hirvonen A, Bell DA, et al. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res 1995;55:5230-7.
40. Wang Y, Ichiba M, Iyadomi M, et al. Effects of genetic polymorphism of metabolic enzymes, nutrition, and lifestyle factors on DNA adduct formation in lymphocytes. Ind Health 1998;36:337-46.
41. Hein DW. N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis. Toxicol Lett 2000;112-113:349-56.
42. Krajinovic M, Richer C, Sinnett H, et al. Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene-gene interaction in the susceptibility to childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 2000;9:557-62.
43. Katoh T, Boissy R, Nagata N, et al. Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma. Int J Cancer 2000;85:46-9.
44. Olshan AF, Weissler MC, Watson MA, et al. GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2000;9:185-91.
45. Smelt VA, Upton A, Adjaye J, et al. Expression of arylamine N-acetyltransferases in pre-term placentas and in human preimplantation embryos. Hum Mol Genet 2000;9:1101-7.
46. Benke G, Sim M, Forbes A, et al. Retrospective assessment of occupational exposure to chemicals in community-based studies: validity and repeatability of industrial hygiene panel ratings. Int J Epidemiol 1997;26:635-42.
47. Stewart PA, Stewart WF. Occupational case-control studies. II. Recommendations for exposure assessment. Am J Ind Med 1994;26:313-26.
48. Fritschi L, Siemiatycki J, Richardson L. Self-assessed versus expert-assessed occupational exposures. Am J Epidemiol 1996;144:521-7.